1. Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling
    Tao Qin et al, 2021, Frontiers in Oncology CrossRef
  2. Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells
    Jianfei Zhu et al, 2019, Life Sciences CrossRef
  3. Nanoparticulated Honokiol Mitigates Cisplatin-Induced Chronic Kidney Injury by Maintaining Mitochondria Antioxidant Capacity and Reducing Caspase 3-Associated Cellular Apoptosis
    Hung-Ting Liu et al, 2019, Antioxidants CrossRef
  4. Honokiol: A Review of Its Anticancer Potential and Mechanisms
    Chon Phin Ong et al, 2019, Cancers CrossRef
  5. Jamming Transitions in Astrocytes and Glioblastoma Are Induced by Cell Density and Tension
    Urszula Hohmann et al, 2022, Cells CrossRef
  6. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets
    Kishore Banik et al, 2019, Pharmacological Research CrossRef
  7. Honokiol, a Polyphenol Natural Compound, Attenuates Cisplatin-Induced Acute Cytotoxicity in Renal Epithelial Cells Through Cellular Oxidative Stress and Cytoskeleton Modulations
    Tse-En J. Wang et al, 2018, Frontiers in Pharmacology CrossRef
  8. Natural Compounds Derived from Plants on Prevention and Treatment of Renal Cell Carcinoma: A Literature Review
    Zhenjie Yin et al, 2023, Advanced Biology CrossRef
  9. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2‐FGFR1 autocrine loop
    Mengyuan Cen et al, 2018, Cancer Medicine CrossRef
  10. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy
    Kao‐Jean Huang et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
  11. Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
    Chih-Cheng Chang et al, 2019, Scientific Reports CrossRef
  12. Honokiol: A review of its pharmacological potential and therapeutic insights
    Abdur Rauf et al, 2021, Phytomedicine CrossRef
  13. Honokiol inhibitsVibrio harveyihemolysin virulence by reducing its haemolytic activity
    Yi Guo et al, 2020, Aquaculture Research CrossRef
  14. The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers
    Abdullah Ayed, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  15. Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
    Essa M. Bajalia et al, 2022, Cancers CrossRef
  16. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach
    Mehreen Ali et al, 2018, Bioinformatics CrossRef
  17. ZC3H4 governs epithelial cell migration through ROCK/p-PYK2/p-MLC2 pathway in silica-induced pulmonary fibrosis
    Rong Jiang et al, 2023, Environmental Toxicology and Pharmacology CrossRef
  18. The Cytoskeleton—A Complex Interacting Meshwork
    null Hohmann et al, 2019, Cells CrossRef
  19. Honokiol: An anticancer lignan
    Abdur Rauf et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  20. Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
    Ekaterina I. Mikhaevich et al, 2023, Research in Pharmaceutical Sciences CrossRef
  21. Pharmacological features, health benefits and clinical implications of honokiol
    Fatima Khatoon et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
  22. The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review
    Inamul Haque et al, 2017, International Journal of Molecular Sciences CrossRef
  23. Inhibition of motility by NEO100 through the calpain-1/RhoA pathway
    Nagore I. Marín-Ramos et al, 2020, Journal of Neurosurgery CrossRef